The fourth subtype was “PBRM1 → SETD2”-driven, a group characterized by highly branched trees (>10 clones per tumor; range [3–23]), the highest mean ITH score in the whole cohort, lower Ki67%, frequent parallel evolution events, and advanced disease stage (Figure 5). This evidence concerns the gene SETD2 and neoplasm.